Please ensure Javascript is enabled for purposes of website accessibility Is now the time to revisit biotech & healthcare? - Janus Henderson Investors - UK financial professionals
For financial professionals in the UK

Is now the time to revisit biotech & healthcare?

Watch the replay of our Biotech webcast featuring Dan Lyons, Portfolio Manager, and Sean Carroll, Client Portfolio Manager, on why why innovation, resilient fundamentals and attractive valuations continue to support a constructive outlook for healthcare and biotech.

15 Sep 2026
35 minute watch

These are the views of the author at the time of publication and may differ from the views of other individuals/teams at Janus Henderson Investors. References made to individual securities do not constitute a recommendation to buy, sell or hold any security, investment strategy or market sector, and should not be assumed to be profitable. Janus Henderson Investors, its affiliated advisor, or its employees, may have a position in the securities mentioned.

 

Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

 

The information in this article does not qualify as an investment recommendation.

 

There is no guarantee that past trends will continue, or forecasts will be realised.

 

Marketing Communication.

 

Glossary